2.78
price up icon6.51%   0.17
after-market Dopo l'orario di chiusura: 2.82 0.04 +1.44%
loading

Ccc Intelligent Solutions Holdings Inc Borsa (CCCC) Ultime notizie

pulisher
Oct 09, 2026

Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research

Oct 09, 2026
pulisher
Oct 02, 2026

C4 Therapeutics Director Donna Roy Grogan Receives 4,618 Shares Instead of Cash Compensation - Kalkine Media

Oct 02, 2026
pulisher
Oct 02, 2026

Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) - Stock Titan

Oct 02, 2026
pulisher
Oct 02, 2026

C4 Therapeutics Inc (CCCC-Q) Stock Price and News - The Globe and Mail

Oct 02, 2026
pulisher
Sep 27, 2026

Form 4 C4 Therapeutics Inc For: 27 September By Investing.com - Investing.com Nigeria

Sep 27, 2026
pulisher
Sep 27, 2026

Form 4 C4 Therapeutics Inc For: 27 September By Investing.com - Investing.com India

Sep 27, 2026
pulisher
Sep 25, 2026

Form 8K C4 Therapeutics Inc For: 25 September By Investing.com - Investing.com Canada

Sep 25, 2026
pulisher
Sep 25, 2026

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society Annual Meeting - Investing News Network

Sep 25, 2026
pulisher
Sep 25, 2026

C4 Therapeutics presents cemsidomide trial biomarker data - Investing.com

Sep 25, 2026
pulisher
Sep 25, 2026

C4 Therapeutics Reports Phase 1 Cemsidomide Biomarker Data Showing T-Cell Activation and Advances Elranatamab Combination Trial - Quiver Quantitative

Sep 25, 2026
pulisher
Sep 25, 2026

C4 Therapeutics: 53% of 20 respond at trial dose - Stock Titan

Sep 25, 2026
pulisher
Sep 25, 2026

C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting - GlobeNewswire Inc.

Sep 25, 2026
pulisher
Sep 25, 2026

In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. - Stock Titan

Sep 25, 2026
pulisher
Sep 23, 2026

Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance

Sep 23, 2026
pulisher
Sep 21, 2026

C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

C4 Therapeutics (Nasdaq:CCCC)Stock Analysis - Simply Wall Street

Sep 21, 2026
pulisher
Sep 13, 2026

CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Sold by Amundi - MarketBeat

Sep 13, 2026
pulisher
Sep 10, 2026

Copart to buy ACV Auctions in $1.9 billion deal - Reuters

Sep 10, 2026
pulisher
Sep 10, 2026

Copart earnings up next amid CCC deal talks, growth strategy test - investing.com

Sep 10, 2026
pulisher
Sep 08, 2026

CCC Intelligent Solutions Holdings Inc. (CCC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Eastern Progress

Sep 08, 2026
pulisher
Sep 07, 2026

Wellington Management Group LLP Invests $17.87 Million in CCC Intelligent Solutions Holdings Inc. Common Stock $CCC - MarketBeat

Sep 07, 2026
pulisher
Sep 05, 2026

C4 Therapeutics: Priced For Perfection Ahead Of 2027 Cemsidomide Readouts (NASDAQ:CCCC) - Seeking Alpha

Sep 05, 2026
pulisher
Sep 02, 2026

CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Purchased by Ancora Advisors LLC - MarketBeat

Sep 02, 2026
pulisher
Sep 01, 2026

Susquehanna Fundamental Investments LLC Cuts Holdings in CCC Intelligent Solutions Holdings Inc. Common Stock $CCC - MarketBeat

Sep 01, 2026
pulisher
Aug 30, 2026

CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Purchased by Thornburg Investment Management Inc. - MarketBeat

Aug 30, 2026
pulisher
Aug 28, 2026

Could Copart (CPRT) Stock Gain from a Transformative Deal for CCC Intelligent Solutions (CCC)? - Yahoo Finance

Aug 28, 2026
pulisher
Aug 26, 2026

CCC on reported talks of selling company - repairerdrivennews.com

Aug 26, 2026
pulisher
Aug 22, 2026

Analysts Offer Insights on Technology Companies: CCC Intelligent Solutions Holdings (CCC) and Lsi Industries (LYTS) - The Globe and Mail

Aug 22, 2026
pulisher
Aug 21, 2026

CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Aug 21, 2026
pulisher
Aug 21, 2026

Analysts Offer Insights on Technology Companies: nCino (NCNO), Salesforce (CRM) and Hon Hai Precision Industry (OtherHNHPF) - The Globe and Mail

Aug 21, 2026
pulisher
Aug 21, 2026

Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice - Yahoo Finance

Aug 21, 2026
pulisher
Aug 19, 2026

Car-Seller Copart Is Among Suitors for Software Firm CCC - Yahoo Finance

Aug 19, 2026
pulisher
Aug 19, 2026

CCC (CCC) Today: Finishes 3.78% Higher at $7.41; Market Levels: Price Remains Between $7.04 Support and $7.78 Resistance for the Current SessionCall Spread Alert - Vinanet

Aug 19, 2026
pulisher
Aug 19, 2026

Copart Reportedly In Talks To Acquire CCC Intelligent Solutions - Auto Recycling World

Aug 19, 2026
pulisher
Aug 19, 2026

Car-Seller Copart Among Suitors for Car Insurance Software Firm CCC - Claims Journal

Aug 19, 2026
pulisher
Aug 18, 2026

Watch Car-Seller Copart Is Among Suitors for Software Firm CCC - Bloomberg.com

Aug 18, 2026
pulisher
Aug 18, 2026

Why CCC Intelligent Solutions Stock Rose Today - Moomoo

Aug 18, 2026
pulisher
Aug 18, 2026

Why CCC Intelligent Solutions Stock Rose Today - Quiver Quantitative

Aug 18, 2026
pulisher
Aug 18, 2026

Longtime Chicago auto tech firm CCC draws takeover interest - Crain's Chicago Business

Aug 18, 2026
pulisher
Aug 18, 2026

CCC Intelligent Solutions gains on report of Copart takeover talks - Seeking Alpha

Aug 18, 2026
pulisher
Aug 18, 2026

Car-Seller Copart Is Among Suitors for Car Insurance Software Firm CCC - Bloomberg.com

Aug 18, 2026
pulisher
Aug 18, 2026

CCC Intelligent (NYSE: CCC) investor to sell 368,930 shares - Stock Titan

Aug 18, 2026
pulisher
Aug 14, 2026

T. Rowe Price (CCC) discloses 7.5% beneficial stake in CCC Intelligent Solutions - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

RA Capital discloses 9.99% C4 Therapeutics (CCCC) stake with warrant blockers - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) - intelligentinvestor.com.au

Aug 13, 2026
pulisher
Aug 13, 2026

Is VRSK Worth Buying as Recurring Revenue Battles a Premium Valuation? - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Verisk's AI Expansion Gains Traction as Insurance Adoption Scales - tradingview.com

Aug 13, 2026
pulisher
Aug 13, 2026

Crash Champions Empowers Team Members with AI and Tools from CCC - The Manila Times

Aug 13, 2026
pulisher
Aug 13, 2026

Crash Champions Expands AI Use to Help Repair Teams Spend More Time - Stock Titan

Aug 13, 2026
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Capitalizzazione:     |  Volume (24 ore):